Claudio Scafoglio,
| University of California, Los Angeles | # of Grants: 2 |
Grants
| Combination immuno and metabolic therapy for early-stage lung adenocarcinoma | 2019 (Cycle 29) | $499,756 |
| Cancer | High Impact Pilot Award | |
| SGLT2 in early diagnosis and treatment of lung cancer | 2017 (Cycle 26) | $414,716 |
| Early Diagnosis of Tobacco-Related Cancer | High Impact Research Project Award | |
Publications